106 related articles for article (PubMed ID: 25810491)
1. Transcription Factor AP2ε: A Potential Predictor of Chemoresistance in Patients With Gastric Cancer.
Sun J; Du N; Li J; Zhou J; Tao G; Sun S; He J
Technol Cancer Res Treat; 2016 Apr; 15(2):285-95. PubMed ID: 25810491
[TBL] [Abstract][Full Text] [Related]
2. TFAP2E-DKK4 and chemoresistance in colorectal cancer.
Ebert MP; Tänzer M; Balluff B; Burgermeister E; Kretzschmar AK; Hughes DJ; Tetzner R; Lofton-Day C; Rosenberg R; Reinacher-Schick AC; Schulmann K; Tannapfel A; Hofheinz R; Röcken C; Keller G; Langer R; Specht K; Porschen R; Stöhlmacher-Williams J; Schuster T; Ströbel P; Schmid RM
N Engl J Med; 2012 Jan; 366(1):44-53. PubMed ID: 22216841
[TBL] [Abstract][Full Text] [Related]
3. TFAP2E methylation promotes 5‑fluorouracil resistance via exosomal miR‑106a‑5p and miR‑421 in gastric cancer MGC‑803 cells.
Jingyue S; Xiao W; Juanmin Z; Wei L; Daoming L; Hong X
Mol Med Rep; 2019 Jul; 20(1):323-331. PubMed ID: 31115533
[TBL] [Abstract][Full Text] [Related]
4.
Murcia O; Jover R; Egoavil C; Perez-Carbonell L; Juárez M; Hernández-Illán E; Rojas E; Alenda C; Balaguer F; Andreu M; Llor X; Castells A; Boland CR; Goel A
Clin Cancer Res; 2018 Jun; 24(12):2820-2827. PubMed ID: 29535127
[No Abstract] [Full Text] [Related]
5. Gelatinases-stimuli nanoparticles encapsulating 5-fluorouridine and 5-aza-2'-deoxycytidine enhance the sensitivity of gastric cancer cells to chemical therapeutics.
Wu FL; Li RT; Yang M; Yue GF; Wang HY; Liu Q; Cui FB; Wu PY; Ding H; Yu LX; Qian XP; Liu BR
Cancer Lett; 2015 Jul; 363(1):7-16. PubMed ID: 25592042
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
[TBL] [Abstract][Full Text] [Related]
7. Expression of orphan nuclear receptor NR4A2 in gastric cancer cells confers chemoresistance and predicts an unfavorable postoperative survival of gastric cancer patients with chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Chang W; Guan W; Liu Y; Shen Q; Yu Y; Zhang H; Cao G
Cancer; 2013 Oct; 119(19):3436-45. PubMed ID: 23821160
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 overexpression predicts prognosis and 5-FU resistance in gastric cancer.
Hu XF; Yao J; Gao SG; Wang XS; Peng XQ; Yang YT; Feng XS
Asian Pac J Cancer Prev; 2013; 14(9):5231-5. PubMed ID: 24175806
[TBL] [Abstract][Full Text] [Related]
9. 5-Fluorouracil chemotherapy of gastric cancer generates residual cells with properties of cancer stem cells.
Xu ZY; Tang JN; Xie HX; Du YA; Huang L; Yu PF; Cheng XD
Int J Biol Sci; 2015; 11(3):284-94. PubMed ID: 25678847
[TBL] [Abstract][Full Text] [Related]
10. TFAP2E methylation status and prognosis of patients with radically resected colorectal cancer.
Park SJ; Kim SM; Hong YS; Lee JL; Kim JE; Kim KP; Hong SM; Jin DH; Kim CW; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC; Kim TW
Oncology; 2015; 88(2):122-32. PubMed ID: 25341849
[TBL] [Abstract][Full Text] [Related]
11. TFAP2E hypermethylation was associated with survival advantage in patients with colorectal cancer.
Zhang ZM; Wang Y; Huang R; Liu YP; Li X; Hu FL; Zhu L; Wang F; Cui BB; Dong XS; Zhao YS
J Cancer Res Clin Oncol; 2014 Dec; 140(12):2119-27. PubMed ID: 24996990
[TBL] [Abstract][Full Text] [Related]
12. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.
Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K
Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967
[TBL] [Abstract][Full Text] [Related]
13. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.
Lei Z; Tan IB; Das K; Deng N; Zouridis H; Pattison S; Chua C; Feng Z; Guan YK; Ooi CH; Ivanova T; Zhang S; Lee M; Wu J; Ngo A; Manesh S; Tan E; Teh BT; So JB; Goh LK; Boussioutas A; Lim TK; Flotow H; Tan P; Rozen SG
Gastroenterology; 2013 Sep; 145(3):554-65. PubMed ID: 23684942
[TBL] [Abstract][Full Text] [Related]
14. FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer.
Nakanishi R; Kitao H; Fujinaka Y; Yamashita N; Iimori M; Tokunaga E; Yamashita N; Morita M; Kakeji Y; Maehara Y
Ann Surg Oncol; 2012 Oct; 19(11):3627-35. PubMed ID: 22526901
[TBL] [Abstract][Full Text] [Related]
15. WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells.
Yuan G; Regel I; Lian F; Friedrich T; Hitkova I; Hofheinz RD; Ströbel P; Langer R; Keller G; Röcken C; Zimmermann W; Schmid RM; Ebert MP; Burgermeister E
Oncogene; 2013 Jan; 32(3):375-87. PubMed ID: 22370641
[TBL] [Abstract][Full Text] [Related]
16. Dichloroacetate attenuates hypoxia-induced resistance to 5-fluorouracil in gastric cancer through the regulation of glucose metabolism.
Xuan Y; Hur H; Ham IH; Yun J; Lee JY; Shim W; Kim YB; Lee G; Han SU; Cho YK
Exp Cell Res; 2014 Feb; 321(2):219-30. PubMed ID: 24342832
[TBL] [Abstract][Full Text] [Related]
17. Aberrant upregulation of ASCL2 by promoter demethylation promotes the growth and resistance to 5-fluorouracil of gastric cancer cells.
Kwon OH; Park JL; Baek SJ; Noh SM; Song KS; Kim SY; Kim YS
Cancer Sci; 2013 Mar; 104(3):391-7. PubMed ID: 23181270
[TBL] [Abstract][Full Text] [Related]
18. Enhanced RegIV expression predicts the intrinsic 5-fluorouracil (5-FU) resistance in advanced gastric cancer.
Ying LS; Yu JL; Lu XX; Ling ZQ
Dig Dis Sci; 2013 Feb; 58(2):414-22. PubMed ID: 23010741
[TBL] [Abstract][Full Text] [Related]
19. HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy.
Nakamura J; Kitajima Y; Kai K; Hashiguchi K; Hiraki M; Noshiro H; Miyazaki K
Int J Cancer; 2010 Sep; 127(5):1158-71. PubMed ID: 20020496
[TBL] [Abstract][Full Text] [Related]
20. Zic1 Promoter Hypermethylation in Plasma DNA Is a Potential Biomarker for Gastric Cancer and Intraepithelial Neoplasia.
Chen X; Lin Z; Xue M; Si J; Chen S
PLoS One; 2015; 10(7):e0133906. PubMed ID: 26207911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
